FIELD: biochemistry.
SUBSTANCE: invention relates to an antibody that binds to TA-MUC1. Also a nucleic acid encoding the said antibody; an expression cassette and a host cell containing the nucleic acid; an expression vector containing said expression cassette; a conjugate for the treatment of diseases associated with TA-MUC1 containing the specified antibody; a composition containing said antibody are disclosed. A method for producing the said antibody is disclosed.
EFFECT: invention makes it possible to effectively treat diseases associated with TA-MUC1.
25 cl, 12 dwg, 3 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-MUC1 DRUG CONJUGATE | 2019 |
|
RU2804703C2 |
| SPECIFIC TO MUCIN-1 POLYPEPTIDE AND ITS USE | 2021 |
|
RU2805840C1 |
| ANTI-LILRB1 ANTIBODY AND USES THEREOF | 2021 |
|
RU2813373C1 |
| PROCOAGULANT ANTIBODIES | 2018 |
|
RU2810094C2 |
| TRISPECIFIC BINDING PROTEINS, RELATED METHODS AND VERSIONS OF USE THEREOF | 2020 |
|
RU2822200C2 |
| C3 BINDING AGENTS AND METHODS OF THEIR USE | 2019 |
|
RU2802307C2 |
| ANTI-LILRB1 ANTIBODY AND ITS USE | 2020 |
|
RU2801535C1 |
| ANTI-IL31 ANTIBODIES FOR VETERINARY USE | 2018 |
|
RU2795485C2 |
| BISPECIFIC FUSION PROTEIN AND ITS USE | 2021 |
|
RU2801528C2 |
| TUMOR-TARGETED AGONISTIC CD28-ANTIGEN-BINDING MOLECULES | 2019 |
|
RU2808030C2 |
